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NEURAL REGENERATION RESEARCH 
PERSPECTIVE
Nicotine-induced dopamine plasticity: 
a gateway to neurotransmitter 
replacement? 
Nicotine, the principal neuroactive component of tobacco, acts on the 
reward systems of smokers, inducing addiction. Experimental evidence in-
dicates that nicotine-induced addiction alters the activity of dopaminergic 
neurons within reward-processing brain centers. The effect of developmen-
tal nicotine exposure on neuroplasticity of identified reward neurocircuitry 
in the adult is finally emerging and begins to be understood at the molecu-
lar, cellular, and behavioral level (Romoli et al., 2019).
For many decades, neurons of the adult central nervous system have been 
assumed to lack the ability to change their neurotransmitter expression 
since this is specified early during development. However, an increase in the 
number of dopamine-expressing neurons in the ventral tegmental area of 
adult mice has been observed following chronic exposure to methamphet-
amines (Kesby et al., 2017). Since maternal nicotine exposure during late 
gestation and lactation has been shown to elicit long-term plasticity altering 
the dopaminergic reward system in rat offspring (Pinheiro et al., 2015), the 
long-term effects of neonatal circuit activation leading to neurotransmitter 
plasticity in adults represent a fundamental question for translational re-
search. 
Few studies have reported the effects of developmental nicotine exposure 
on enhanced susceptibility to substance abuse in adulthood (Heath and 
Picciotto, 2009; Zhu et al., 2012). Romoli et al. (2019) provided strong evi-
dence that neonatal nicotine exposure greatly increases nicotine preference 
in adult mice through an activity-dependent mechanism of dopamine plas-
ticity also known as neurotransmitter switching. The characterization of the 
molecular adaptations that paralleled changes in reward-seeking behaviors 
revealed the key cellular players associated with dopamine plasticity in-
duced by developmental exposure to substances of abuse. The mouse model 
system offered cutting-edge genetic tools to identify the specific neuronal 
pool recruited for this nicotine-induced form of neuroplasticity in the ven-
tral tegmental area. We found that developmental nicotine exposure primes 
the reward center to become “hyperplastic” at the dopaminergic level. Such 
neuroplasticity mediates an increase in the number of neurons expressing 
the dopaminergic marker, tyrosine hydroxylase (TH), following a secondary 
nicotine exposure in adulthood. 
Several new insights emerged from our recent report. We highlight them 
here for the scientific community.
Through the discovery of the link between nicotine-induced neurotrans-
mitter plasticity in the reward centers and enhanced consumption of nico-
tine and other substances of abuse, our study is a reminder that the brain is 
plastic and malleable during the earliest phase of life and external interfer-
ence affecting normal development can elicit long-lasting effects, even when 
they are not immediately detectable after exposure to altered environmental 
stimuli. Neurons of the ventral tegmental area acquired a “molecular mem-
ory” of neonatal nicotine exposure. By increasing the expression of nicotine 
receptors and boosting calcium signaling coupled with ectopic transcrip-
tional regulation of the molecular marker Nurr1, a protein normally found 
only in dopaminergic differentiated neurons, non-dopaminergic neurons 
acquire a dormant “readiness” to switch to a dopaminergic program when 
properly motivated by nicotine re-exposure in adulthood. 
This pre-clinical work (Romoli et al., 2019) identified new cellular and 
molecular targets that may guide future clinical studies to redefine treat-
ment strategies. Because we found that this form of nicotine-induced neuro-
plasticity facilitates addiction to other addictive substances, such as ethanol 
in adults, uncovering the mechanism contributing to increased addiction 
susceptibility opens the gate to the discovery of new ways to interfere with 
the mechanism of drug-mediated plasticity and prevent the negative conse-
quences on reward-seeking behavior in adulthood.
Finally, our research showed that neonatal nicotine exposure through 
lactation has direct translational implications since the nicotine concentra-
tions used in our studies are comparable to the concentrations human new-
borns are exposed to when lactating from smokers. However, tobacco-use 
by pregnant smokers and nursing moms, including nicotine patches which 
are occasionally used during pregnancy to protect smokers and their babies 
from the deleterious effects of smoke compounds, is not carefully regulated. 
For instance, nicotine patches deliver a high concentration of nicotine in the 
blood stream of pregnant women and nursing moms. Because post-mortem 
studies in humans (Aumann et al., 2016) have shown that dopamine plastici-
ty discovered in rodents (Aumann et al., 2011; Dulcis et al., 2013) can also 
occur in the human dopaminergic system, our findings on the deleterious 
effects of neonatal nicotine exposure on normal physiology of the reward 
system might have implications applicable to human physiology and drug 
addiction. This knowledge should have a profound impact on state policies 
that fails to regulate the use of substitutive nicotine therapies by pregnant 
and postpartum women via nicotine patches or electronic cigarettes. 
Current clinical treatments of neurotransmitter-associated disorders 
include: pharmacological agents developed to restore appropriate levels 
of neurotransmitters or modulate neurotransmitter receptor activation, 
embryonic stem cell transplantation to replace degenerated cells, surgical 
removal of brain nuclei to reduce excitation in epilepsy, electroconvulsive 
therapies, deep brain stimulation, and transcranial magnetic stimulation. 
Activity-dependent neurotransmitter plasticity induced by selective acti-
vation of brain circuits might provide spatial refinement of current clin-
ical treatments. Recruitment and integration of neurons with the correct 
transmitter identity and connectivity into damaged circuits via induction 
of neurotransmitter plasticity could increase the precision and effectiveness 
of future clinical approaches. In the postembryonic nervous system, where 
neurogenesis is restricted to a few regions in the brain and the extracellular 
environment no longer provides appropriate cues to guide axonal pathfind-
ing of ectopically and surgically implanted embryonic stem cells, the activi-
ty-mediated recruitment of reserve pool neurons (Dulcis and Spitzer, 2012) 
for neurotransmitter plasticity opens new hope for a functional rescue of 
damaged neural circuits.
What is in the horizon for our future research? Nicotine-mediated do-
pamine induction in the reward system affecting reward-seeking behavior 
(Romoli et al., 2019) is the first detailed example of activity-dependent 
neurotransmitter plasticity induced by a psychostimulant. The knowledge 
on the molecular and cellular signature required for neurons to switch to 
a dopaminergic phenotype could represent the gateway to recruitment of 
other neurocircuits and could prove to be of clinical impact on patients with 
neurodegenerative disorders such as Parkinson’s disease (PD) and Alzhei-
mer’s disease. 
Because PD is a serious debilitating neurological disorder resulting from 
neurodegeneration of dopamine neurons in the substantia nigra (SN) and 
given that low concentrations of nicotine appear to mitigate and delay the 
degenerative effects of PD (Huang et al., 2009), our future research will 
focus on understanding the mechanism involved in this form of neuropro-
tection. To build upon our previous published work on activity-dependent 
dopamine plasticity (Dulcis and Spitzer, 2008; Dulcis et al., 2013, 2017) and 
recent findings on nicotine-induced dopamine expression (Romoli et al., 
2019), we are currently investigating whether nicotine-mediated activation 
of SN circuits can convert non-dopaminergic neurons to a dopaminergic 
phenotype potentially enabling them to release de-novo synthesized dopa-
mine in the caudate nucleus. This possibility is encouraged by the fact that 
when massive cell death occurs in the neuromelanin-pigmented and dopa-
mine-containing SN, the dopaminergic neurons of the SN are not the only 
neurons projecting to the striatum (González-Hernández and Rodríguez, 
2000). The SN is composed of the pars compacta (SNc), which is mainly 
dopaminergic, and the pars reticulata (SNr), organized in large clusters of 
GABAergic neurons with thin intermingled stripes of dopaminergic neu-
rons (González-Hernández and Rodríguez, 2000). Remarkably, the SNr 
remains intact in PD animal models (González-Hernández and Rodríguez, 
2000), and the combination of retrograde labeling and immunocytochem-
istry has shown that clusters of GABAergic neurons of the SNr already 
project to the caudate nucleus (González-Hernández and Rodríguez, 2000). 
The existence of this non-dopaminergic nigrostriatal pathway was elegantly 
confirmed by Rodriguez and Gonzalez-Hernandez (2000) by antidromic 
responses to striatal stimulation, retrograde labeling, and resistance to neu-
rotoxin 6-OHDA. These GABAergic neurons represent more than 80% of 
nigrostriatal neurons in PD-animal models. Consistent with their potential 
role as a reserve pool (Dulcis and Spitzer, 2012) that could rescue the loss 
of dopaminergic neurons, non-dopaminergic nigrostriatal neurons share 
afferents with dopaminergic neurons in addition to sharing the same target, 
the striatum (Gerfen, 1984). 
To this aim, we investigated the effects of 2-week nicotine exposure via 
voluntary oral administration on dopamine expression in the SN of adult 
mice (P60). Experimental mice had access to a 50 mg/L nicotine in 1% 
saccharin solution while control animals to a 1% saccharin water solution. 
After 14 days of drinking nicotine solution, mice (P74) were sacrificed and 
their brains processed for diaminobenzidine immunohistochemistry to 
label the dopaminergic marker TH. TH-expressing dopaminergic cells were 
quantified with unbiased stereological counts of images obtained with a Lei-
ca DM4B microscope equipped with Stereologer2000 software. As shown in 
Figure 1, chronic nicotine treatment increased the number of TH-positive 
cells by 50% in SNr, but did not change TH expression in SNc. Chronic nic-
otine treatment did not affect the total number of neurons in the SNr (data 
not shown), indicating that the increase in TH-positive neurons was not 
due to an increase of neuroproliferation nor cell migration. Our findings 
suggest the presence of an endogenous reserve pool of neurons in the SNr 
that can be recruited to express a TH phenotype by chronic nicotine expo-
sure. GABAergic neurons (González-Hernández and Rodríguez, 2000) of 
the SNr could represent a neuronal reserve pool available for recruitment to 
nicotine-mediated TH upregulation or responsive to other forms of targeted 
activity-dependent manipulations.
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Investigating whether other forms of circuit activation, other than nic-
otine-mediated activity, could be sufficient to recruit non-dopaminergic 
nigrostriatal reserve pool to acquire a dopaminergic phenotype and reverse 
behavioral deficits in animal models for PD is part of our research mission. 
If successful, this approach could represent a paradigm shift in the way we 
intervene to restore loss of dopamine function in the future. We envision 
how induction of circuit-specific neurotransmitter plasticity might reveal an 
effective approach to accomplish neurotransmitter replenishment to treat 
neurodegenerative disorders as well as other neurological conditions associ-
ated with dopamine and other transmitter imbalance and dysfunction such 
as depression, schizophrenia, and drug addiction. 
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Figure 1 Effects of nicotine intake 
on TH expression in the substantia 
nigra (SN).
Bright-field image of coronal sec-
tion (30 µm) through the SN of con-
trol (A) and nicotine-treated adult 
(P60) mice (B) immunostained 
for dopaminergic marker, tyrosine 
hydroxylase (TH). Dopaminergic 
neurons  (arrows) are indicated in 
both compacta (SNc) and reticulata 
(SNr). Scale bars: 100 µm. Stereo-
logical quantification of the number 
of TH-expressing cells in the SNc 
(C) and SNr (D). ****P < 0.0001.
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